34120588|t|Memantine ameliorates cognitive deficit in AD mice via enhancement of entorhinal-CA1 projection.
34120588|a|BACKGROUND: Memantine, a low- to moderate-affinity uncompetitive N-methyl-D-aspartate receptor antagonist, has been shown to improve cognitive functions in animal models of Alzheimer's disease (AD). Here we treated APP/PS1 AD mice with a therapeutic dose of memantine (20 mg/kg/day) and examined its underlying mechanisms in ameliorating cognitive defects. METHODS: Using behavioral, electrophysiological, optogenetic and morphology approaches to explore how memantine delay the pathogenesis of AD. RESULTS: Memantine significantly improved the acquisition in Morris water maze (MWM) in APP/PS1 mice without affecting the speed of swimming. Furthermore, memantine enhanced EC to CA1 synaptic neurotransmission and promoted dendritic spine regeneration of EC neurons that projected to CA1. CONCLUSIONS: Our study reveals the underlying mechanism of memantine in the treatment of AD mice.
34120588	0	9	Memantine	Chemical	MESH:D008559
34120588	22	39	cognitive deficit	Disease	MESH:D003072
34120588	43	45	AD	Disease	MESH:D000544
34120588	46	50	mice	Species	10090
34120588	109	118	Memantine	Chemical	MESH:D008559
34120588	270	289	Alzheimer's disease	Disease	MESH:D000544
34120588	291	293	AD	Disease	MESH:D000544
34120588	316	319	PS1	Gene	19164
34120588	320	322	AD	Disease	MESH:D000544
34120588	323	327	mice	Species	10090
34120588	355	364	memantine	Chemical	MESH:D008559
34120588	435	452	cognitive defects	Disease	MESH:D003072
34120588	556	565	memantine	Chemical	MESH:D008559
34120588	592	594	AD	Disease	MESH:D000544
34120588	605	614	Memantine	Chemical	MESH:D008559
34120588	688	691	PS1	Gene	19164
34120588	692	696	mice	Species	10090
34120588	751	760	memantine	Chemical	MESH:D008559
34120588	945	954	memantine	Chemical	MESH:D008559
34120588	975	977	AD	Disease	MESH:D000544
34120588	978	982	mice	Species	10090
34120588	Negative_Correlation	MESH:D008559	MESH:D000544
34120588	Negative_Correlation	MESH:D008559	MESH:D003072

